We have studied severe sepsis (including melioidosis and staphylococcal disease) since 1986 in our permanently manned microbiology research site in the large provincial hospital in Ubon Ratchathani, Northeast Thailand. We have initiated and coordinated the Tracking Resistance to Artemisinin Collaboration (TRAC) a large multi-centre clinical study of the spread and nature of artemisinin resistant malaria. This study has 15 study sites in 10 coiuntries; in Thailand the sites are in the border provinces, in Mae Sod, Surin, Sisaket and Ranong. We have two clinical study sites in Cambodia studying malaria (Pailin) and clinical epidemiology (Siem Reap). Since 2002 we have studied severe malaria at Chittagong Medical College Hospital in Bangladesh, at Ispat Hospital in Rourkela, India, and in Beira, Mozambique. We have a vibrant and productive network of other collaborative study sites throughout South-East Asia, South Asia and Africa.
In addition to MORU's permanent Units (shown in blue on the map below), we also operate a range of study sites, shown in orange on the map.